NCT02260505 2024-01-05
ImadGist
Centre Leon Berard
Phase 3 Completed
Clinical Trials
10 trialsNCT03426722 2020-07-13
L-carnitine vs Placebo for the Treatment of Muscle Cramps After Imatinib in Gastrointestinal Stromal Tumors
Asan Medical Center
Phase 3 Completed
NCT01151852 2020-01-14
Rechallenge of Imatinib in GIST Having no Effective Treatment: RIGHT
Asan Medical Center
Phase 3 Completed
NCT01265810 2017-11-13
COMTT
Impaqtt Foundation
Phase 3 Completed
NCT02866045 2016-08-15
EUS-FNB vs. Single-incision Needle-knife (SINK) Biopsy for Gastrointestinal SELs
Unity Health Toronto
Phase 3 Unknown
NCT01462994 2016-03-17
Detection of CF-DNA in Patients With Gastrointestinal Stromal Tumors (GIST)
Technical University of Munich
Phase 3 Completed
NCT02576080 2015-10-15
GIGIST
Assistance Publique Hopitaux De Marseille
Phase 3 Unknown
NCT00293124 2015-08-13
Open-label Trial of GlivecWith Unresectable or Metastatic Malignant Gastrointestinal Stromal Tumors
Central European Cooperative Oncology Group
Phase 3 Completed
NCT01031628 2013-09-09
Study of Dose Escalation Versus no Dose Escalation of Imatinib in Metastatic Gastrointestinal Stromal Tumors (GIST) Patients
Sarcoma Alliance for Research through Collaboration
Phase 3 Terminated
NCT00116935 2011-12-30
Study Comparing 12 Months Versus 36 Months of Imatinib in the Treatment of Gastrointestinal Stromal Tumor (GIST)
Scandinavian Sarcoma Group
Phase 3 Completed